Clinical Trials Logo

Clinical Trial Summary

The investigators will perform a 1-year clinical trial measuring objective compliance during mandibular advancement device (MAD) treatment.

The investigators will enroll 50 patients that received treatment with a titratable, duobloc MAD (RespiDent Butterfly®, RespiDent, Nijlen, Belgium) and participated in the original study "Objective versus subjective compliance with oral appliance therapy for obstructive sleep apnea hypopnea syndrome", registered at Clinical Trials.gov (NCT01284881).

Active microsensors (TheraMon®,Handelsagentur Gschladt, Hargelsberg, Austria) are provided by the Handelsagentur Gschladt without any costs. The sampling interval of the recording will be done at a rate of 1 measurement per 15 minutes (every 900 seconds). Using this sample interval, the capacity of the active microsensor allows for data acquisition during a 100 day period.

A follow-up appointment is scheduled +/- 265 days after the start of the original study. A second follow-up visit is scheduled again 1 year after the start of the original study.

The objective measurement of MAD wear time (total hours of wear time and the mean hours of wear per night over the respective period) will be based on the assumption that the MAD has been worn when the chip records a temperature intraorally.


Clinical Trial Description

This clinical trial is an extension to trial 10/48/340, registered at Clinical Trials.gov (NCT01284881). ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01533623
Study type Interventional
Source University Hospital, Antwerp
Contact
Status Completed
Phase N/A
Completion date July 2012

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05547477 - Continuous EMG Measurements in Children With Asthma During Sleep
Completed NCT01503164 - Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism N/A
Recruiting NCT00863421 - Sleep Disordered Breathing in Patients With Chronic Heart Failure N/A
Completed NCT00841906 - Alice PDx User/Validation Extended Trial N/A
Not yet recruiting NCT05462834 - Impact of Nocturnal Hypoxemia on Glucose in High Altitude Sleep Disordered Breathing N/A
Recruiting NCT01785199 - Effects of Head Elevation by a Bed on Sleep-disordered Breathing Phase 1
Recruiting NCT06043830 - Managing Opioid Related Sleep Apnea With Acetazolamide Phase 2
Recruiting NCT04351698 - SMILES: Study of Montelukast in Sickle Cell Disease Phase 2/Phase 3
Active, not recruiting NCT05643352 - Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring N/A
Recruiting NCT03142022 - Sleep-disordered Breathing After Solid Organ Transplantation
Recruiting NCT05336890 - Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
Recruiting NCT05466864 - Screening of OSA in Hospitalized Stroke Patients Using BSP N/A
Recruiting NCT05661747 - Dental Appliance to Treat SDB in Children Phase 4
Completed NCT02855515 - Drug-Induced Sleep Endoscopy for the Optimisation of Treatment of Patients With Obstruction Sleep Apnoea N/A
Recruiting NCT05575401 - Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy N/A
Completed NCT02923505 - Effect of Positive Airway Pressure Therapy on Hospitalization and Mortality in SDB Patients With Comorbid Chronic Obstructive Pulmonary Disease (COPD) or/and Heart Failure (HF)
Completed NCT06154577 - Tongue Morphology and Posterior Airway Space as Predictors of Response in Patientswith Hypoglossal Nerve Stimulation Therapy
Recruiting NCT04331821 - READ-ASV Registry - Phase II
Completed NCT02830074 - Treatment of Sleep-disordered Breathing in Patients With SCI N/A
Completed NCT02245659 - Effect of CPAP Treatment on Glycemic Control in Gestational Diabetes: A Pilot Randomized-Controlled Trial N/A